I write and edit on science, technology, medicine and the environment, as a freelancer for publications and research organizations. Among my day jobs, I was associate director for communications and public affairs at Whitehead Institute for Biomedical Research, editor in chief of MIT’s technologyreview.com and executive editor of pcworld.com. Contact: email@example.com, 617.244.2676 home office, 857.231.0483 mobile, @ebender00, Skype ebender00, http://www.linkedin.com/in/benderwrite, 86 Greenlawn Avenue, Newton, MA 02459 USA
Unpacking the black box in artificial intelligence for medicine
Deep learning will radically change aspects of our medical care. How well do we need to understand how AI tools work?
Breaking out of the egg
Can the latest techniques speed up the dangerously slow production of flu vaccines?
Now in development: off-the-shelf stem cells
Their potential as universal donors promises to make regenerative medicine more broadly practical.
Biotechs race to develop stem cell treatments for diabetes
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
The Scientist, 2019
Beyond ‘you are what you eat’
Purdue researchers work to unravel obesity biology and behaviors, with some surprising results.
Purdue College of Health and Human Services, 2019
Building a silk road for agriculture
Benedetto Marelli designs materials based on silk proteins that can preserve crops and make seeds more productive.
MIT Industrial Liaison Program, 2019
Regulating the gene-therapy revolution
The medical regulatory authorities ride a wave of clinical studies for gene therapies.
Delivering on DNA
Mark Bathe creates viral-like nucleic acid particles uniquely structured for precisely targeting drugs.
MIT ILP, 2018
Getting cancer drugs into the brain
Before they can get to work, treatments for brain cancer must bypass a formidable obstacle — the blood–brain barrier.
Cost of cancer drugs: something has to give
Many patients are being priced out of treatments that could save their lives.
Managed Care Magazine, 2018
Nature Outlook (lead editor)
With storms intensifying and oceans on the rise, Boston weighs strategies for staying dry
A multi-billion-dollar seawall is among climate adaptation options under consideration for the iconic coastal city.
Putting digital health monitoring tools to the test
Fitbits and smartphone apps can aid in managing chronic conditions–but only if people stay engaged.
Transgenic fish are ready for us. Are we ready for them?
After decades of regulatory and legal challenges, AquaBounty aims to bring genetically engineered salmon to U.S. and Canadian markets next year.
Oxstem: Doubling down on disruption
Startup drives university research to commercialize small molecules that activate stem cells inside patients.
(Some) frogs are better parents than we thought
Nocturnal fieldwork sheds light on how parental sex roles evolve.
BU Research, 2017
Cells on trial
Four regenerative and immune-system therapies taking on the toughest cases of inflammatory bowel disease.
Open competitions bring new minds, skills and collaborations to problems in biomedical research.
Turning technology into startup success
Robert Langer, who has helped launch dozens of biotech startups, looks at the long tricky road to commercialize medical innovations.
MIT ILP, 2016
Fingerprinting the brain
Zhongming Liu integrates imaging techniques for ambitious projects mapping neural networks.
Purdue College of Engineering, 2016
Big data in biomedicine
Nature Outlook (lead editor)